GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - FRA:GXI - DE000A0LD6E6 - Common Stock
24.7 EUR
-0.16 (-0.64%)
GXI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of GXI have multiple concerns. GXI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
GXI had positive earnings in the past year.
In the past year GXI had a positive cash flow from operations.
In the past 5 years GXI has always been profitable.
In the past 5 years GXI always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 0.50%, GXI is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
With a Return On Equity value of 1.67%, GXI is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
GXI's Return On Invested Capital of 2.79% is on the low side compared to the rest of the industry. GXI is outperformed by 84.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GXI is significantly below the industry average of 13.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a Profit Margin of 1.04%. This is amonst the worse of the industry: GXI underperforms 84.21% of its industry peers.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
The Operating Margin of GXI (5.99%) is worse than 84.21% of its industry peers.
GXI's Operating Margin has improved in the last couple of years.
GXI has a worse Gross Margin (26.89%) than 73.68% of its industry peers.
GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GXI remains at a similar level compared to 1 year ago.
The number of shares outstanding for GXI has been increased compared to 5 years ago.
The debt/assets ratio for GXI is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.95, we must say that GXI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.95, GXI is doing worse than 84.21% of the companies in the same industry.
GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
GXI has a worse Debt to Equity ratio (1.22) than 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.95 |
ROIC/WACC0.35
WACC7.95%
2.3 Liquidity
GXI has a Current Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
GXI's Current ratio of 0.98 is on the low side compared to the rest of the industry. GXI is outperformed by 78.95% of its industry peers.
A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
With a Quick ratio value of 0.52, GXI is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased strongly by -19.08% in the last year.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
The Revenue has grown by 11.83% in the past year. This is quite good.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
GXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.02% yearly.
GXI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.44% yearly.
EPS Next Y-33.1%
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
EPS Next 5Y6.02%
Revenue Next Year13.41%
Revenue Next 2Y8.75%
Revenue Next 3Y7.82%
Revenue Next 5Y7.44%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GXI is valuated cheaply with a Price/Earnings ratio of 6.69.
Based on the Price/Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of GXI to the average of the S&P500 Index (25.89), we can say GXI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.10, the valuation of GXI can be described as very cheap.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
GXI is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.69 | ||
| Fwd PE | 7.1 |
4.2 Price Multiples
GXI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GXI is cheaper than 94.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.26 |
4.3 Compensation for Growth
GXI's earnings are expected to decrease with -2.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
5. Dividend
5.1 Amount
With a yearly dividend of 0.16%, GXI is not a good candidate for dividend investing.
The stock price of GXI dropped by -45.14% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 0.74, GXI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, GXI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.16% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
FRA:GXI (11/14/2025, 7:00:00 PM)
24.7
-0.16 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.48%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap853.14M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts65.22
Price Target40.1 (62.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.16% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-35.45%
PT rev (3m)-39.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)-18.09%
EPS NY rev (3m)-40.58%
Revenue NQ rev (1m)-2.84%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)-3.1%
Revenue NY rev (3m)-3.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.69 | ||
| Fwd PE | 7.1 | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | 3.36 | ||
| P/B | 0.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.26 |
EPS(TTM)3.69
EY14.94%
EPS(NY)3.48
Fwd EY14.08%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY29.73%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.95 |
F-Score4
WACC7.95%
ROIC/WACC0.35
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-33.1%
EPS Next 2Y-13.78%
EPS Next 3Y-2.75%
EPS Next 5Y6.02%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year13.41%
Revenue Next 2Y8.75%
Revenue Next 3Y7.82%
Revenue Next 5Y7.44%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year113.62%
EBIT Next 3Y38.46%
EBIT Next 5Y21.19%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -33.1% in the next year.